UBS Group AG - PERNIX THERAPEUTICS HLDGS IN ownership

PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 120 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q1 2015. The put-call ratio across all filers is 3.07 and the average weighting 0.3%.

Quarter-by-quarter ownership
UBS Group AG ownership history of PERNIX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q3 2016$17,000
-32.0%
27,743
-51.5%
0.00%
Q2 2016$25,000
+400.0%
57,185
+1005.0%
0.00%
Q1 2016$5,000
-94.3%
5,175
-82.7%
0.00%
Q4 2015$88,000
-57.1%
29,929
-53.9%
0.00%
Q3 2015$205,000
-8.5%
64,900
+71.2%
0.00%
Q2 2015$224,000
-49.0%
37,900
-7.8%
0.00%
Q1 2015$439,000
+41.6%
41,096
+24.5%
0.00%
Q4 2014$310,00033,0000.00%
Other shareholders

There were no reported owners of PERNIX THERAPEUTICS HLDGS IN in Q1 2015.

NameSharesValueWeighting ↓
View complete list of PERNIX THERAPEUTICS HLDGS IN shareholders